SKL-2841, a dual antagonist of MCP-1 and MIP-1 beta, prevents bleomycin-induced skin sclerosis in mice - Concepedia

Concepedia

Publication | Closed Access

SKL-2841, a dual antagonist of MCP-1 and MIP-1 beta, prevents bleomycin-induced skin sclerosis in mice

24

Citations

15

References

2006

Year

Mizuho Kimura, Yutaka Kawahito, Masahide Hamaguchi, Takashi Nakamura, Masayuki Okamoto, Yukiharu Matsumoto, Hirahito Endo, Aihiro Yamamoto, Hidetaka Ishino, Makoto Wada,

Biomedicine & Pharmacotherapy

SclerostinCutaneous BiologyImmunologyCell DeathBleomycin-induced Skin SclerosisDual AntagonistDermatologyExperimental DermatologyMedicineCell BiologyCell SignalingMip-1 Beta

References

	Year	Citations

Page 1

Page 1